1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Brazil Pharmaceuticals and Healthcare Report Q4 2016

Brazil Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 107 pages

Includes 3 FREE quarterly updates
BMI View:

Political instability and thus risk will remain elevated over the coming quarters in Brazil, contributing to increasing uncertainty in terms of policy direction within the pharmaceuticals and healthcare sector. Nonetheless, over a multiyear timeframe, the Brazilian electorate will demand progress on promised reforms, including higher-quality public services and greater government transparency, boosting the long-term growth outlook for the sector. Stated government commitment to such reforms bodes well for the country's healthcare landscape going forward.

Headline Expenditure Projections Pharmaceuticals: BRL66.8bn (USD20.1bn) in 2015 to BRL71.7bn (USD20.0bn) in 2016; +7.4% in local currency terms and -0.1% in US dollar terms. Forecast in local currency terms is unchanged from Q316. Healthcare: BRL502.5bn (USD150.8bn) in 2015 to BRL549.7bn (USD153.6bn) in 2016; +9.4% in local currency terms and +1.8% in US dollar terms. Forecast in local currency terms has been revised from Q316 due to new historical data.

Table Of Contents

Brazil Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Brazil 2014-2020) 7
SWOT 10
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Brazil 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Brazil 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Brazil 2014-2020) 31
Industry Risk/Reward Index 32
Americas Risk/Reward Index 32
Brazil Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 41
Intellectual Property Issues 42
Pricing Regime 45
Reimbursement Regime 46
Market Overview 49
Healthcare Sector 49
Table: Healthcare Resources (Brazil 2010-2015) 50
Table: Healthcare Personnel (Brazil 2010-2015) 50
Table: Healthcare Activity (Brazil 2010-2015) 51
Research and Development 51
Biotechnology 53
Clinical Trials 54
Epidemiology 55
Competitive Landscape 58
Research-Based Industry 58
Table: Top 10 Pharmaceutical Companies In Brazil By Sales In 2013 58
Table: Multinational Pharmaceutical Company Activity 59
Generic Drugmakers 59
Pharmaceutical Distribution 62
Pharmaceutical Retail Sector 64
Company Profile 66
Ache/Biosintetica 66
Cristália 69
EMS Sigma 72
Eurofarma 75
GlaxoSmithKline 77
Medley 80
Merck and Co 82
Novartis 84
Pfizer 87
Roche 90
Sanofi 93
Demographic Forecast 96
Table: Population Headline Indicators (Brazil 1990-2025) 97
Table: Key Population Ratios (Brazil 1990-2025) 97
Table: Urban/Rural Population and Life Expectancy (Brazil 1990-2025) 98
Table: Population By Age Group (Brazil 1990-2025) 98
Table: Population By Age Group % (Brazil 1990-2025) 99
Glossary 101
Methodology 103
Pharmaceutical Expenditure Forecast Model 103
Healthcare Expenditure Forecast Model 103
Notes On Methodology 104
Risk/Reward Index Methodology 105
Index Overview 106
Table: Pharmaceutical Risk/Reward Index Indicators 106
Indicator Weightings 107

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.